Ginkgo Bioworks Holdings Inc.(DNA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DNA Ginkgo Bioworks Holdings Inc.

Market Closed 02-20 16:00:00 EST

9.22

-0.47

-4.85%

盘后9.23

+0.01+0.10%

19:51 EST

High9.65	Low9.14	Vol642.34K
Open9.55	D1 Closing9.69	Amplitude5.26%
Mkt Cap558.64M	Tradable Cap382.97M	Total Shares60.59M
T/O5.99M	T/O Rate1.55%	Tradable Shares41.54M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DNA","market":"US","secType":"STK","nameCN":"Ginkgo Bioworks Holdings Inc.","latestPrice":9.22,"timestamp":1771621200000,"preClose":9.69,"halted":0,"volume":642344,"hourTrading":{"tag":"盘后","latestPrice":9.2293,"preClose":9.22,"latestTime":"19:51 EST","volume":14954,"amount":137879.6272,"timestamp":1771635101012,"change":0.0093,"changeRate":0.001009,"amplitude":0.019523},"delay":0,"changeRate":-0.048503611971104116,"floatShares":41536899,"shares":60590219,"eps":-6.213238,"marketStatus":"Market Closed","change":-0.47,"latestTime":"02-20 16:00:00 EST","open":9.55,"high":9.65,"low":9.14,"amount":5991567.719728,"amplitude":0.052632,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.213238,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":9.69,"preHourTrading":{"tag":"盘前","latestPrice":9.42,"preClose":9.69,"latestTime":"09:15 EST","volume":6767,"amount":64556.895786,"timestamp":1771596908428,"change":-0.27,"changeRate":-0.027864,"amplitude":0.030929},"postHourTrading":{"tag":"盘后","latestPrice":9.2293,"preClose":9.22,"latestTime":"19:51 EST","volume":14954,"amount":137879.6272,"timestamp":1771635101012,"change":0.0093,"changeRate":0.001009,"amplitude":0.019523},"volumeRatio":0.7153294896485777,"impliedVol":1.1272,"impliedVolPercentile":0.757},"requestUrl":"/m/hq/s/DNA/wiki","defaultTab":"wiki","newsList":[{"id":"2612407022","title":"Ginkgo Bioworks Holdings Inc. published an update to their financial calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2612407022","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612407022?lang=en_us&edition=fundamental","pubTime":"2026-02-19 21:02","pubTimestamp":1771506124,"startTime":"0","endTime":"0","summary":"Ginkgo Bioworks Holdings Inc. published an update to their financial calendar               Ginkgo Bioworks Holdings Inc. will host a fourth-quarter and full-year 2025 results presentation and Q&A ses","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL3hHm9N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNA","BK4109","BK4139","BK4121"],"gpt_icon":0},{"id":"2612944547","title":"Ginkgo Bioworks and Invaio Sciences partner to develop peptide crop protection manufacturing strains","url":"https://stock-news.laohu8.com/highlight/detail?id=2612944547","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612944547?lang=en_us&edition=fundamental","pubTime":"2026-02-18 21:07","pubTimestamp":1771420048,"startTime":"0","endTime":"0","summary":"Ginkgo Bioworks Holdings Inc. has entered a collaboration with Invaio Sciences to develop and optimize microbial strains and fermentation processes for manufacturing peptide-based agricultural crop protection products at commercial scale. The effort aims to enable cost-effective production of next-generation peptide inputs that can help growers combat pests resistant to conventional chemicals.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nNDL6KK48p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNA","BK4109","BK4121","BK4139"],"gpt_icon":0},{"id":"2612456974","title":"Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-Based Agricultural Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2612456974","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612456974?lang=en_us&edition=fundamental","pubTime":"2026-02-18 21:00","pubTimestamp":1771419607,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nTUAC0LYJC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNA","BK4109","BK4121","BK4139"],"gpt_icon":0},{"id":"1136384703","title":"Deep Analysis | The Ingrained Cultural Imperative of Chinese New Year Homecomings","url":"https://stock-news.laohu8.com/highlight/detail?id=1136384703","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136384703?lang=en_us&edition=fundamental","pubTime":"2026-02-15 08:31","pubTimestamp":1771115472,"startTime":"0","endTime":"0","summary":"The first day of the Spring Festival holiday, also the final day before Lunar New Year's Eve—where are you reading this? Still on a hurried journey home, or already back in your native land?...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4109","BK4121","DNA"],"gpt_icon":0},{"id":"2610831927","title":"Aprea Therapeutics Strengthens Global Patent Portfolio in DNA Damage Response (DDR) Cancer Therapeutics, Paving Way for Pipeline Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2610831927","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610831927?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:30","pubTimestamp":1770903000,"startTime":"0","endTime":"0","summary":"New patents granted in 2025 in Australia and Japan bolster global IP coverage for Aprea’s WEE1 and ATR programs. Core patent families are expected to provide exclusivity into 2045. Lead WEE1 inhibitor","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/12/3237181/0/en/Aprea-Therapeutics-Strengthens-Global-Patent-Portfolio-in-DNA-Damage-Response-DDR-Cancer-Therapeutics-Paving-Way-for-Pipeline-Growth.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DNA","BK4539","LENZ","BK4109","BK4139","BK4121"],"gpt_icon":0},{"id":"2610954945","title":"4basebio Directors Lift Stakes in Synthetic DNA Specialist","url":"https://stock-news.laohu8.com/highlight/detail?id=2610954945","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610954945?lang=en_us&edition=fundamental","pubTime":"2026-02-12 00:02","pubTimestamp":1770825770,"startTime":"0","endTime":"0","summary":"An announcement from 4basebio UK Societas ( ($GB:4BB) ) is now available. 4basebio PLC reported that non-executive directors Dr. Heikki Lanckriet a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/4basebio-directors-lift-stakes-in-synthetic-dna-specialist?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/4basebio-directors-lift-stakes-in-synthetic-dna-specialist?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4139","DNA","BK4109"],"gpt_icon":0},{"id":"2610933587","title":"The Safety DNA: Decoding UL 9540B's Unseen Protections","url":"https://stock-news.laohu8.com/highlight/detail?id=2610933587","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610933587?lang=en_us&edition=fundamental","pubTime":"2026-02-11 17:49","pubTimestamp":1770803340,"startTime":"0","endTime":"0","summary":"HEFEI, China, Feb. 11, 2026 /PRNewswire/ -- In Australia, the introduction of federal and state incentive programs has accelerated household adoption of energy storage systems, as homeowners seek to reduce electricity costs and strengthen energy independence. Amid this rapid market expansion, a fundamental question comes demands attention: when an energy storage system becomes part of the home, how does its safety move beyond a promise to deliver reliable, everyday protection that Australians can truly trust?As a global leader in renewable energy technology, Sungrow places safety at the core of its energy storage innovation. The Sungrow SBH Series has now achieved UL 9540B certification, one of the most stringent safety standards for residential energy storage systems below 20kWh. Widely recognized across the industry, UL 9540B evaluates a system's ability to prevent fire propagation and mitigate risk under extreme failure conditions.When internal pressure of the system rises abnormall","market":"sh","thumbnail":"https://mma.prnewswire.com/media/2901969/Resi_Tech.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2901969/Resi_Tech.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/the-safety-dna-decoding-ul-9540bs-unseen-protections-302684920.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6088","BK4505","BK6522","BK4183","DNA","BK4023","BK4121","ULVR.UK","TUYA","BK4585","UN","LU0124676726.USD","BK4139","BK4109","BK4592","BK4526","UL","5AL.SI","BK4588","BK4509","LU0689626769.HKD"],"gpt_icon":0},{"id":"2609936586","title":"Ginkgo Bioworks jumps after OpenAI comment on working together","url":"https://stock-news.laohu8.com/highlight/detail?id=2609936586","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609936586?lang=en_us&edition=fundamental","pubTime":"2026-02-06 03:15","pubTimestamp":1770318916,"startTime":"0","endTime":"0","summary":"14:14 EST Ginkgo Bioworks (DNA) jumps after OpenAI comment on working together Published first on TheFly – the ultimate source for real-time, marke...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ginkgo-bioworks-jumps-after-openai-comment-on-working-together-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ginkgo-bioworks-jumps-after-openai-comment-on-working-together-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4109","BK4139","DNA","BK4121"],"gpt_icon":0},{"id":"2608336972","title":"Twist Bioscience Raises Outlook As AI DNA Demand Builds Profit Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2608336972","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608336972?lang=en_us&edition=fundamental","pubTime":"2026-02-04 09:26","pubTimestamp":1770168377,"startTime":"0","endTime":"0","summary":"Twist Bioscience (NasdaqGS:TWST) reported its twelfth consecutive quarter of revenue growth.\nThe company raised its full year outlook, citing momentum in AI enabled DNA synthesis and wider use of its platform.\nManagement also reiterated a focus on progressing toward profitability alongside scaling the business.\n\nTwist Bioscience, a provider of synthetic DNA and related tools, operates at the intersection of biotechnology and AI driven research. Its platform supports customers in areas such...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/twist-bioscience-raises-outlook-as-ai-dna-demand-builds-prof","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/twist-bioscience-raises-outlook-as-ai-dna-demand-builds-prof","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4588","DNA","BK4121","BK4528","BK4023","BK4139","BK4543","BK4551","BK4587","BK4109","TWST"],"gpt_icon":1},{"id":"2608893360","title":"Pacific Biosciences of California Closes $48.1 Million Sale of DNA Sequencing Assets to Illumina","url":"https://stock-news.laohu8.com/highlight/detail?id=2608893360","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608893360?lang=en_us&edition=fundamental","pubTime":"2026-02-02 23:37","pubTimestamp":1770046639,"startTime":"0","endTime":"0","summary":"Pacific Biosciences of California  said Monday it closed the sale of select intellectual property and other assets to Illumina for $48.1 million in cash.The assets were related to its short-read DNA sequencing technology and related clustering, sequencing reagent, and detection technologies, the company said.Under the terms of the agreement, Illumina assumed certain liabilities and granted a non-exclusive license certain intellectual property back to Pacific Biosciences, the company said.Price: 2.16, Change: -0.11, Percent Change: -4.65","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4534","DNA","BK4121","BK4548","PACB","BK4109","BK4535","BK4585","ILMN","BK4588"],"gpt_icon":1},{"id":"2608867556","title":"Guardant reports publication of circulating tumor DNA for MRD detection study","url":"https://stock-news.laohu8.com/highlight/detail?id=2608867556","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608867556?lang=en_us&edition=fundamental","pubTime":"2026-02-02 22:20","pubTimestamp":1770042034,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced publication of the largest study to date evaluating circulating tumor DNA for MRD detection in patients with resecte...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-reports-publication-of-circulating-tumor-dna-for-mrd-detection-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-reports-publication-of-circulating-tumor-dna-for-mrd-detection-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4196","GH","BK4121","BK4588","BK4139","BK4551","DNA","BK4109","BK4535"],"gpt_icon":0},{"id":"2608865599","title":"MGI Tech to Purchase Entire Stakes in Gene Imaging, DNA/RNA Sequencing Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2608865599","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608865599?lang=en_us&edition=fundamental","pubTime":"2026-02-02 19:48","pubTimestamp":1770032884,"startTime":"0","endTime":"0","summary":"MGI Tech  plans to purchase the entire stake in Shenzhen BGI Sanjianqifa Technology and Hangzhou BGI Xufeng Technology for 365.7 million yuan, according to a Monday disclosure to the Shanghai bourse.MGI Tech, a gene sequencer and laboratory automation equipment manufacturer, will purchase the stakes after the acquisition of Sanjianqifa's spatiotemporal omics technology tha maps gene expression, and Xufeng's nanopore sequencing technology for decoding of DNA and RNA.The transaction price for the acquisition of Sanjianqifa is at 158 million yuan, while that of BGI Xufeng is at 207.7 million yuan.Following the acquisition of Sanjianqifa, MGI Tech plans to boost the capital in the company by 70 million yuan and BGI Xufeng by 60 million yuan, the filing said.MGI will also loan 70 million yuan to Xufeng with an interest rate of 2.5% and a term of three years, the filing said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RNA","BK4505","BK4121","BK4588","BK4109","BK4106","688114","BK4227","BK4585","DNA","IE0009354923.USD","BK4139","MGI","BK0251"],"gpt_icon":0},{"id":"2606375697","title":"Sonim Technologies Rebrands as DNA X, Shifts Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2606375697","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606375697?lang=en_us&edition=fundamental","pubTime":"2026-01-28 06:36","pubTimestamp":1769553380,"startTime":"0","endTime":"0","summary":"The latest update is out from Sonim Technologies ( ($SONM) ). On January 23, 2026, Sonim Technologies implemented an amendment to its asset purchas...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sonim-technologies-rebrands-as-dna-x-shifts-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sonim-technologies-rebrands-as-dna-x-shifts-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4109","BK4139","BK4121","DNA"],"gpt_icon":0},{"id":"2606203784","title":"The Genesis Mission Has a 270-Day Timeline – And You’re Already Late","url":"https://stock-news.laohu8.com/highlight/detail?id=2606203784","media":"InvestorPlace","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606203784?lang=en_us&edition=fundamental","pubTime":"2026-01-27 20:56","pubTimestamp":1769518560,"startTime":"0","endTime":"0","summary":"The government is taking equity stakes in American companies. Here are the next Genesis Mission stocks to buy before the capital hits.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"investorplace_stock_picks","url":"https://investorplace.com/hypergrowthinvesting/2026/01/miss-these-genesis-mission-stocks-and-youll-regret-it-for-a-decade/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://investorplace.com/hypergrowthinvesting/2026/01/miss-these-genesis-mission-stocks-and-youll-regret-it-for-a-decade/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investorplace_stock_picks","symbols":["NVD3.UK","NVDD","AI","NVDS","MUD","PPTA","NVDQ","SNVD.UK","HON","NVDX","LEU","TWST","IONQ","NVDY","DIPS","TMQ","3NVD.UK","MULL","SKYT","SLI","TMO","NVD","NVDW","OKLO","NNE","RXRX","INTC","NVII","NVD2.UK","BWXT","NVDU","SDGR","CEG","NVDG","ABSI","ROK","WOLF","DNA","TER","2NVD.UK","SYM"],"gpt_icon":1},{"id":"2603684339","title":"Ginkgo Bioworks CEO to Present at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2603684339","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603684339?lang=en_us&edition=fundamental","pubTime":"2026-01-13 21:03","pubTimestamp":1768309381,"startTime":"0","endTime":"0","summary":"Ginkgo Bioworks Holdings Inc. will participate in the 44th Annual J.P. Morgan Healthcare Conference, with Co-Founder and CEO Jason Kelly scheduled to present on Thursday, January 15, 2026, at 10:30 a.m. PT . Further details and presentation slides will be available on the company's investor relations website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ginkgo Bioworks Holdings Inc. published the original content used to generate this news brief via PR Newswire  on January 13, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL7zGFm9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4109","BK4139","DNA","BK4121"],"gpt_icon":0},{"id":"1121580267","title":"Converge Bio Secures $25 Million Funding with Backers Including Bessemer Ventures and Executives from Meta, OpenAI, and Wiz","url":"https://stock-news.laohu8.com/highlight/detail?id=1121580267","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121580267?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:01","pubTimestamp":1768305676,"startTime":"0","endTime":"0","summary":"As pharmaceutical and biotechnology companies seek methods to shorten R&D cycles and improve success rates to combat ever-increasing research costs, artificial intelligence is rapidly making inroads...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","DNA","BK4139","RNA","BK4109","IE0009354923.USD","BK4585","BK4505","BK4121"],"gpt_icon":0},{"id":"2602581249","title":"What Does CEO Pay and Insider Selling Reveal About Twist Bioscience’s (TWST) Synthetic DNA Ambitions?","url":"https://stock-news.laohu8.com/highlight/detail?id=2602581249","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602581249?lang=en_us&edition=fundamental","pubTime":"2026-01-10 15:16","pubTimestamp":1768029368,"startTime":"0","endTime":"0","summary":"In 2025, Twist Bioscience’s CEO and Chair Emily M. Leproust received total compensation of US$13,781,570, while recent insider activity showed only stock sales and no purchases alongside adjustments in institutional holdings. \nAt the same time, multiple brokerage firms reiterated positive views on Twist Bioscience’s semiconductor-based DNA synthesis platform, collectively maintaining an “Outperform” stance backed by confidence in its synthetic biology technology. \nBuilding on this renewed...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/what-does-ceo-pay-and-insider-selling-reveal-about-twist-bio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/what-does-ceo-pay-and-insider-selling-reveal-about-twist-bio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4588","DNA","BK4121","BK4139","BK4109","TWST"],"gpt_icon":0},{"id":"2601355386","title":"U.S. RESEARCH ROUNDUP-Alcoa, BlackRock, Evercore","url":"https://stock-news.laohu8.com/highlight/detail?id=2601355386","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601355386?lang=en_us&edition=fundamental","pubTime":"2026-01-08 15:12","pubTimestamp":1767856359,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Alcoa, BlackRock, EvercoreJan 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alcoa, BlackRock...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nL4N3Y90FF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CACC","BX","GDYN","ARES","EXE","AZTA","AMG","EPAM","LU1804176565.USD","HLNE","LU0130103400.USD","LU0971096721.USD","FHI","EVR","JLL","BWA","COMP","DNA","KKR","PJT","MSM","IVZ","PAYC","GM","FIGR","BK4139","CTSH","BLK","APD","SG9999002232.USD","IE","RIVN","LU2272731600.USD","HLI","PCTY","AA","F","CG","GMED","INTU","HALO","ACI","CBRE","APO","SG9999002224.SGD","BK4534","GLUE","BK4533","FCX","OS"],"gpt_icon":1},{"id":"2601304123","title":"We Think Bumitama Agri (SGX:P8Z) Might Have The DNA Of A Multi-Bagger","url":"https://stock-news.laohu8.com/highlight/detail?id=2601304123","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601304123?lang=en_us&edition=fundamental","pubTime":"2026-01-08 07:47","pubTimestamp":1767829648,"startTime":"0","endTime":"0","summary":"To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/5121000-choice1-main-header/1585186829794","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5121000-choice1-main-header/1585186829794"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/sg/food-beverage-tobacco/sgx-p8z/bumitama-agri-shares/news/we-think-bumitama-agri-sgxp8z-might-have-the-dna-of-a-multi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/sg/food-beverage-tobacco/sgx-p8z/bumitama-agri-shares/news/we-think-bumitama-agri-sgxp8z-might-have-the-dna-of-a-multi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EBIT","BK4121","BK6095","BK4109","DNA","BK4139","SG9999006266.SGD","P8Z.SI","BK6509"],"gpt_icon":0},{"id":"2601422818","title":"YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2601422818","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601422818?lang=en_us&edition=fundamental","pubTime":"2026-01-06 22:00","pubTimestamp":1767708000,"startTime":"0","endTime":"0","summary":"Taipei, Taiwan, Jan.  06, 2026  (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/06/3213679/0/en/YD-Bio-Enters-into-MOU-to-Merge-with-EG-BioMed-Advancing-DNA-Methylation-Driven-AI-Platforms-for-Cancer-Diagnostics-and-Drug-Development.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4528","BK4587","BK4121","BK4023","BK4588","AI","LU0077335932.USD","IE0002270589.USD","EG","IE00B19Z3581.USD","BK4543","BK4109","LU0211331839.USD","BK4019","BK4585","DNA","BK4551","BK4139","IE00B19Z3B42.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ginkgobioworks.com","stockEarnings":[{"period":"1week","weight":-0.0075},{"period":"1month","weight":-0.0573},{"period":"3month","weight":0.1285},{"period":"6month","weight":-0.2653},{"period":"1year","weight":-0.1934},{"period":"ytd","weight":0.1095}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.00587},{"month":2,"riseRate":0.4,"avgChangeRate":-0.118562},{"month":3,"riseRate":0,"avgChangeRate":-0.186194},{"month":4,"riseRate":0.25,"avgChangeRate":-0.075483},{"month":5,"riseRate":0.4,"avgChangeRate":-0.028577},{"month":6,"riseRate":0.6,"avgChangeRate":0.042062},{"month":7,"riseRate":0.8,"avgChangeRate":0.169362},{"month":8,"riseRate":0.2,"avgChangeRate":-0.142535},{"month":9,"riseRate":0.8,"avgChangeRate":0.092966},{"month":10,"riseRate":0.2,"avgChangeRate":-0.069954},{"month":11,"riseRate":0.2,"avgChangeRate":-0.122886},{"month":12,"riseRate":0.4,"avgChangeRate":-0.023276}],"exchange":"NYSE","name":"Ginkgo Bioworks Holdings Inc.","nameEN":"Ginkgo Bioworks Holdings Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ginkgo Bioworks Holdings Inc.(DNA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Ginkgo Bioworks Holdings Inc.(DNA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Ginkgo Bioworks Holdings Inc.,DNA,Ginkgo Bioworks Holdings Inc.股票,Ginkgo Bioworks Holdings Inc.股票老虎,Ginkgo Bioworks Holdings Inc.股票老虎国际,Ginkgo Bioworks Holdings Inc.行情,Ginkgo Bioworks Holdings Inc.股票行情,Ginkgo Bioworks Holdings Inc.股价,Ginkgo Bioworks Holdings Inc.股市,Ginkgo Bioworks Holdings Inc.股票价格,Ginkgo Bioworks Holdings Inc.股票交易,Ginkgo Bioworks Holdings Inc.股票购买,Ginkgo Bioworks Holdings Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ginkgo Bioworks Holdings Inc.(DNA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Ginkgo Bioworks Holdings Inc.(DNA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction